Apotex Inc - Strategic SWOT Analysis Review
[Report Updated: 31-01-2019]

Introduction

Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – GlobalData’s summarization of the company’s business strategy.

- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. The company also offers biosimilars, active pharmaceutical ingredients and pharmaceuticals. It carries out the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Montreal, Richmond Hill, Brantford, Windsor, Winnipeg, Toronto, Etobicoke, Mississauga, London, Calgary and Vancouver. It serves patients, healthcare providers and payers, governments and other pharmaceutical manufacturers. It operates through subsidiaries, joint ventures and licensing agreements across Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex Inc Key Recent Developments

Dec 19,2018: Apotex names Jeff Watson as leader after CEO Jack Kay departs

Aug 10,2018: FDA approves first generic drug under new CGT designation

Aug 08,2018: CannTrust and Apotex accelerate partnership to fuel global expansion in medical cannabis market

May 09,2018: Apotex Announces Proposed Merger of AUS & NZ Operations

Mar 08,2018: Advisory - Chipped pills in additional packages of Alysena 21 and 28 birth control pills

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

• Table of Contents

  Table of Contents 3

  List of Tables 4

  List of Figures 4

  Section 1 - About the Company 5

  Apotex Inc - Key Facts 5

  Apotex Inc - Key Employees 6

  Apotex Inc - Key Employee Biographies 7

  Apotex Inc - Major Products and Services 8

  Apotex Inc - History 10

  Apotex Inc - Company Statement 12

  Apotex Inc - Locations And Subsidiaries 13

  Head Office 13

  Other Locations & Subsidiaries 13

  Section 2 – Company Analysis 15

  Company Overview 15

  Apotex Inc - Business Description 16

  Apotex Inc - SWOT Analysis 17

  SWOT Analysis - Overview 17

  Apotex Inc - Strengths 17

  Apotex Inc - Weaknesses 18

  Apotex Inc - Opportunities 19

  Apotex Inc - Threats 20

  Apotex Inc - Key Competitors 21

  Section 3 – Company’s Lifesciences Financial Deals and Alliances 22

  Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22

  Apotex Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23

  Apotex Inc, Recent Deals Summary 24

  Section 4 – Company’s Recent Developments 25

  Aug 10, 2018: FDA approves first generic drug under new CGT designation 25

  Aug 08, 2018: CannTrust and Apotex accelerate partnership to fuel global expansion in medical cannabis market 26

  May 09, 2018: Apotex Announces Proposed Merger of AUS & NZ Operations 27

  Mar 08, 2018: Advisory - Chipped pills in additional packages of Alysena 21 and 28 birth control pills 28

  Section 5 – Appendix 29

  Methodology 29

  About GlobalData 29

  Contact Us 29

  Disclaimer 29

List Of Tables
in Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

List of Tables

Apotex Inc, Key Facts 5

Apotex Inc, Key Employees 6

Apotex Inc, Key Employee Biographies 7

Apotex Inc, Major Products and Services 8

Apotex Inc, History 10

Apotex Inc, Subsidiaries 13

Apotex Inc, Key Competitors 21

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23

Apotex Inc, Recent Deals Summary 24

List Of Figures, Charts and Diagrams
in Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

List of Figures

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22

Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 23

Additional Details

Publisher

Global Data

Publisher Information

Reference

230729 | GDPH6309SA

Number of Pages

29

Report Format

PDF

Related Reports